PLLA+HA
A dual-action biostimulating product based on the patented REGENEXA® technology for progressive volumization, firming and structural rejuvenation of the skin. Instead of creating artificial volume, the system combines immediate hydration of the dermis with long-term regeneration of the collagen framework, demonstrating stronger, smoother and naturally restored skin over time.
The product induces controlled and long-term skin regeneration through the gradual activation of cellular signaling pathways.
Stage 1 (Hydration and Volume): The hydrophilic component of medium molecular weight hyaluronic acid ensures isotonic tissue balance, instantly saturates the dermal matrix with moisture and smoothes microrelief irregularities.
Stage 2 (Biostimulation): Highly concentrated microparticles of polylactic acid (PLLA) form a depot in the deep layers, acting as a powerful trigger for fibroblasts. They stimulate extracellular repair and neosynthesis of collagen fibers, which step by step increases the density of the dermis, restores its elasticity, and ensures stable long-term structural integrity of tissues.
The product induces controlled and long-term skin regeneration through the gradual activation of cellular signaling pathways.
Stage 1 (Hydration and Volume): The hydrophilic component of medium molecular weight hyaluronic acid ensures isotonic tissue balance, instantly saturates the dermal matrix with moisture and smoothes microrelief irregularities.
Stage 2 (Biostimulation): Highly concentrated microparticles of polylactic acid (PLLA) form a depot in the deep layers, acting as a powerful trigger for fibroblasts. They stimulate extracellular repair and neosynthesis of collagen fibers, which step by step increases the density of the dermis, restores its elasticity, and ensures stable long-term structural integrity of tissues.
Fill in the fields and we will contact you!
Please check the correctness of your phone number before submitting the application!
Download the files and learn more about the product
Indications for use
The drug is designed for the targeted restoration of depleted dermis density and correction of pronounced signs of aging:
Composition:
Sterile and isotonic formula with optimized pH level to minimize swelling and maximize patient comfort:
Release form:
Total active substance content: 200 mg of combined PLLA + HA complex in one syringe (100 mg of each component). The large volume of the syringe is adapted for large-scale professional modeling.
The drug is designed for the targeted restoration of depleted dermis density and correction of pronounced signs of aging:
- General deterioration of skin quality, loss of natural elasticity and firmness of tissues.
- Presence of fine lines, deep facial and static wrinkles on the face.
- Pronounced nasolabial folds and marionette wrinkles.
- Deficiency of soft tissue volume, the need for complete facial volumization and correction of temporal depressions.
- The need for clear contouring of the cheeks and chin line
Composition:
Sterile and isotonic formula with optimized pH level to minimize swelling and maximize patient comfort:
- Polylactic acid (PLLA): 100 mg per syringe (concentration 20 mg/ml). Main regenerative component with long-lasting effect.
- Sodium hyaluronate (HA): 100 mg per syringe (concentration 20 mg/ml). Hydrophilic matrix that supports cellular stability.
Release form:
- Package: 1 pre-filled sterile syringe with a volume of 5 ml.
Total active substance content: 200 mg of combined PLLA + HA complex in one syringe (100 mg of each component). The large volume of the syringe is adapted for large-scale professional modeling.